Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Human Molecular Genetics|August 30, 2014
Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptorsMadoka Iida, Masahisa Katsuno, Hideaki Nakatsuji, et al.
Gastro Hep Advances|November 19, 2024
Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/BevacizumabYuki Sasaki, Kazuyuki Matsumoto, Akinobu Takaki, et al.
Scientific Reports|August 17, 2019
Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activationMasahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, et al.
Plos One|March 4, 2014
The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancerTakayuki Goto, Naoki Terada, Takahiro Inoue, et al.
Nature Medicine|October 2, 2012
Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tractMakoto Minamiyama, Masahisa Katsuno, Hiroaki Adachi, et al.
Journal of Neurochemistry|February 1, 2013
Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron diseaseQiang Qiang, Hiroaki Adachi, Zhe Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2024
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumabTatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabYasuto Takeuchi, Masahiko Sue, Nozomi Miyake, et al.
Journal of Clinical Microbiology|March 23, 2018
Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR AssaysYuki Higashimoto, Masaru Ihira, Yu Miyazaki, et al.
Journal of Gastroenterology and Hepatology|November 8, 2018
Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenibTakuya Adachi, Kazuhiro Nouso, Koji Miyahara, et al.
Pageof 16